184 related articles for article (PubMed ID: 35378058)
1. Potential anti-acanthamoebic effects through inhibition of CYP51 by novel quinazolinones.
Ahmed U; Ho KY; Simon SE; Saad SM; Ong SK; Anwar A; Tan KO; Sridewi N; Khan KM; Khan NA; Anwar A
Acta Trop; 2022 Jul; 231():106440. PubMed ID: 35378058
[TBL] [Abstract][Full Text] [Related]
2. Antiamoebic activity of 3-aryl-6,7-dimethoxyquinazolin-4(3H)-one library against Acanthamoeba castellanii.
Shahbaz MS; Anwar A; Saad SM; Kanwal ; Anwar A; Khan KM; Siddiqui R; Khan NA
Parasitol Res; 2020 Jul; 119(7):2327-2335. PubMed ID: 32476058
[TBL] [Abstract][Full Text] [Related]
3. Anti-amoebic activity of a series of benzofuran/benzothiophene derivatives against Acanthamoeba castellanii belonging to the T4 genotype.
Akbar N; El-Gamal MI; Zaraei SO; Saeed BQ; Khan NA; Siddiqui R
J Appl Microbiol; 2023 Jan; 134(1):. PubMed ID: 36626774
[TBL] [Abstract][Full Text] [Related]
4. Novel antiacanthamoebic compounds belonging to quinazolinones.
Anwar A; Shahbaz MS; Saad SM; Kanwal ; Khan KM; Siddiqui R; Khan NA
Eur J Med Chem; 2019 Nov; 182():111575. PubMed ID: 31415900
[TBL] [Abstract][Full Text] [Related]
5. Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51).
Lamb DC; Warrilow AG; Rolley NJ; Parker JE; Nes WD; Smith SN; Kelly DE; Kelly SL
Antimicrob Agents Chemother; 2015 Aug; 59(8):4707-13. PubMed ID: 26014948
[TBL] [Abstract][Full Text] [Related]
6. (‒)-Epicatechin reveals amoebicidal activity against Acanthamoeba castellanii by activating the programmed cell death pathway.
Lê HG; Kang JM; Võ TC; Yoo WG; Hong Y; Na BK
Phytomedicine; 2024 Mar; 125():155389. PubMed ID: 38306720
[TBL] [Abstract][Full Text] [Related]
7. Anti-amoebic effects of synthetic acridine-9(10H)-one against brain-eating amoebae.
Ahmed U; Manzoor M; Qureshi S; Mazhar M; Fatima A; Aurangzeb S; Hamid M; Khan KM; Khan NA; Rashid Y; Anwar A
Acta Trop; 2023 Mar; 239():106824. PubMed ID: 36610529
[TBL] [Abstract][Full Text] [Related]
8. Domain-Swap Dimerization of
Sharma V; Shing B; Hernandez-Alvarez L; Debnath A; Podust LM
Mol Pharmacol; 2020 Dec; 98(6):770-780. PubMed ID: 33008918
[TBL] [Abstract][Full Text] [Related]
9. Potential anti-amoebic activity of sulfonate- and sulfamate-containing carboxamide derivatives against pathogenic Acanthamoeba castellanii belonging to the genotype T4.
Akbar N; Siddiqui R; El-Gamal MI; Zaraei SO; Saeed BQ; Alawfi BS; Khan NA
Parasitol Int; 2024 Feb; 98():102814. PubMed ID: 37806551
[TBL] [Abstract][Full Text] [Related]
10. Malabaricones from the fruit of Myristica cinnamomea King as potential agents against Acanthamoeba castellanii.
Ahmed U; Sivasothy Y; Khan KM; Khan NA; Wahab SMA; Awang K; Othman MA; Anwar A
Acta Trop; 2023 Dec; 248():107033. PubMed ID: 37783284
[TBL] [Abstract][Full Text] [Related]
11. Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris.
Kulsoom H; Baig AM; Siddiqui R; Khan NA
Exp Parasitol; 2014 Nov; 145 Suppl():S115-20. PubMed ID: 24726699
[TBL] [Abstract][Full Text] [Related]
12. Repositioning of Guanabenz in Conjugation with Gold and Silver Nanoparticles against Pathogenic Amoebae
Anwar A; Mungroo MR; Anwar A; Sullivan WJ; Khan NA; Siddiqui R
ACS Infect Dis; 2019 Dec; 5(12):2039-2046. PubMed ID: 31612700
[TBL] [Abstract][Full Text] [Related]
13. Antiamoebic activity of synthetic tetrazoles against Acanthamoeba castellanii belonging to T4 genotype and effects of conjugation with silver nanoparticles.
Anwar A; Yi YP; Fatima I; Khan KM; Siddiqui R; Khan NA; Anwar A
Parasitol Res; 2020 Jun; 119(6):1943-1954. PubMed ID: 32385711
[TBL] [Abstract][Full Text] [Related]
14. Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii.
Anwar A; Numan A; Siddiqui R; Khalid M; Khan NA
Parasit Vectors; 2019 Jun; 12(1):280. PubMed ID: 31159839
[TBL] [Abstract][Full Text] [Related]
15. The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellanii.
Shing B; Singh S; Podust LM; McKerrow JH; Debnath A
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094126
[TBL] [Abstract][Full Text] [Related]
16. Cinnamic acid and lactobionic acid based nanoformulations as a potential antiamoebic therapeutics.
Akbar N; Kawish M; Jabri T; Khan NA; Shah MR; Siddiqui R
Exp Parasitol; 2023 Mar; 246():108474. PubMed ID: 36708943
[TBL] [Abstract][Full Text] [Related]
17. Antidiabetic Drugs and Their Nanoconjugates Repurposed as Novel Antimicrobial Agents against Acanthamoeba
Anwar A; Siddiqui R; Raza Shah M; Khan NA
J Microbiol Biotechnol; 2019 May; 29(5):713-720. PubMed ID: 31030451
[No Abstract] [Full Text] [Related]
18. Novel Tetrazoles against Acanthamoeba castellanii Belonging to the T4 Genotype.
Wehelie YI; Khan NA; Fatima I; Anwar A; Kanwal K; Khan KM; Siddiqui R; Tong YK; Anwar A
Chemotherapy; 2022; 67(3):183-192. PubMed ID: 34724675
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potent and Selective Inhibitors of
Hargrove TY; Lamb DC; Wawrzak Z; Hull M; Kelly SL; Guengerich FP; Lepesheva GI
J Med Chem; 2024 May; 67(9):7443-7457. PubMed ID: 38683753
[No Abstract] [Full Text] [Related]
20. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae.
Rice CA; Colon BL; Chen E; Hull MV; Kyle DE
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008353. PubMed ID: 32970675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
